Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2000, p. 3538-3543, Vol. 38, No. 10
Molecular Pathology Section, Division of
Biomedical Sciences, Department of Infectious Diseases and Medical
Microbiology, Imperial College of Science, Technology and Medicine,
London SW7 2AZ,1 and Department of
Virology, Public Health Laboratory Service, Fulwood, Preston PR2
8DW,4 United Kingdom, and Key Laboratory
of Viral Heart Disease, Shanghai Institute of Cardiovascular Diseases,
Shanghai Medical University, Shanghai
200032,2 and Chuxiong Institute of
Keshan Disease, Yunnan Province 675000,3
People's Republic of China
Received 3 March 2000/Returned for modification 12 July
2000/Accepted 27 July 2000
An association of enterovirus infection with endemic cardiomyopathy
(Keshan disease [KD]) and outbreaks of myocarditis in selenium-deficient rural areas of southwestern China has been established. Enteroviruses have been isolated from patients with KD or
during outbreaks of myocarditis in last two decades. Six of these
isolates grew readily in cell lines (Vero or HEp-2) and were
investigated by a novel molecular typing method apart from serotyping
and pathogenicity. A neutralization assay identified two isolates from
KD as coxsackievirus serotype B2 (CVB2) and two isolates from
myocarditis as coxsackievirus serotype B6 (CVB6) but failed to type the
remaining two isolates, also from myocarditis. Direct nucleotide
sequencing of reverse transcription-PCR products amplified from the 5'
nontranslated region (5'NTR) of these viruses confirmed that they
belong to a phylogenetic cluster consisting of coxsackie B-like
viruses, including some echovirus serotypes. Sequence analysis of the
coding region for viral capsid protein VP1 showed that two isolates
serotyped as CVB2 have the highest amino acid sequence homology with
CVB2 and that the remaining four isolates, two CVB6 and the two unknown
serotypes, are most closely related to the sequence of CVB6. Sequences
among these isolates varied from 82.3 to 99% in the 5'NTR and from 69 to 99% in VP1, indicating no cross contamination. The pathogenicity of these viruses in adult and suckling mice was assessed. None caused pathologic changes in the hearts of adult MF-1 or SWR mice, although pancreatitis was evident. However, the four CVB6-like viruses caused
death in suckling mice, similar to a virulent coxsackievirus group B3
laboratory strain. In conclusion, the sequence data confirm that
coxsackievirus group B serotypes are predominant in the region in which
KD is endemic and may be the etiological agents in outbreaks of
myocarditis. VP1 genotyping of enteroviruses is accurate and reliable.
Animal experiments indicate that isolates may differ in pathogenicity.
Enteroviruses are the most common
etiological agents of human viral myocarditis and are associated with
some cases of dilated cardiomyopathy (DCM) (5, 26, 38). DCM
alone afflicts approximately 5 to 8 persons per 100,000 per year
worldwide (25, 36). Results from recent studies have also
demonstrated a possible etiological role of enterovirus infection in a
particular form of heart muscle disease, selenium deficiency-related
endemic cardiomyopathy (Keshan disease [KD]), seen in China (23,
24, 45). Enteroviruses also cause outbreaks in some
subpopulations, such as young children within maternity units or
nurseries (7). Such outbreaks, occurring in
selenium-deficient areas, may affect the general population and are
more severe, with high mortality. The incidence of outbreaks of
enteroviral myocarditis in selenium-deficient regions of southwestern China has increased in the last decade (15 and our
unpublished data). During an outbreak in 1991, 67 cases in patients 2 to 75 years old were reported, with 16 fatalities within 24 h of
onset (15).
KD is endemic exclusively in selenium-deficient rural areas of China,
from the northeast to the southwest, including 14 provinces and
autonomous regions (13). Its clinical features are low body selenium content and acute or chronic episodes of heart disorder characterized by cardiogenic shock, arrythemia, and/or congestive heart
failure, with an enlarged heart. Four types of the disease are seen:
acute, subacute, chronic, and latent or compensated. Pathologically, it
is characterized by multifocal myocardial necrosis and fibrous
replacement throughout the myocardium, with various degrees of cellular
infiltration and calcification, depending upon the type of disease. In
some cases, the pathologic changes are similar to those of myocarditis
or DCM (13, 22). Selenium deficiency has been considered a
major cause since KD was first reported in 1935. Selenium
supplementation has led to a decrease in the incidence of KD in areas
of endemicity (11) but has not eliminated KD. In addition, a
seasonal and annual fluctuation of KD incidence is seen. In the
Chuxiong region of southwestern China, for instance, the prevalence of
endemic KD is higher in summer and higher in some years than in others
(13). This fact suggests an infectious etiology of KD in
southwestern China.
Various enteroviruses have been isolated from patients with KD or
during outbreaks of myocarditis in the selenium-deficient Chuxiong
region of southwestern China. Most were coxsackievirus group B (CVB)
strains, but some of them could not be identified antigenically using
traditional serotyping methods (8, 15, and our
unpublished data). Selenium deficiency increases the cardiovirulence of
CVB3 in animal models by changing the viral genomic sequence (4). However, little is known about the biological
properties of enteroviruses prevalent in selenium-deficient areas or
areas in which KD is endemic, partly because of the inability to
identify some isolates using conventional serotyping methods.
Sixty-six human enterovirus serotypes have been distinguished on the
basis of a neutralization assay (28). Although this assay is
generally reliable and is used routinely, it is labor-intensive and
time-consuming and may fail to identify a clinical isolate because of
antigenic variation, recombination, or the presence of multiple
serotypes. Nucleotide sequencing of the 5' nontranslated region (5'NTR)
and the capsid protein VP4-VP2 junction has been used as a diagnostic
and epidemiologic tool for some enteroviruses. However, the sequence of
these regions does not correspond to the serotype (2, 32),
which is determined mainly by sequences encoding epitopes on viral
capsid protein VP1. Recent studies have found that sequences coding for
VP1, particularly the 3' half, correlate with results of the
neutralization assay. This information has been confirmed for prototype
strains and for clinical isolates of various serotypes (30,
31) and is likely to be useful for isolates that are difficult or
impossible to type using standard immunological reagents.
In the present study, six enteroviruses isolated from patients with
subacute KD or during outbreaks of viral myocarditis in selenium-deficient areas were characterized by nucleotide sequencing of
the 5'NTR and the VP1 coding region and determination of their pathogenicity in adult and suckling mice.
Enteroviruses.
Of six virus isolates in this study, two were
isolated from cardiac blood obtained at autopsy from patients with
subacute KD in 1985 and 1987 in the Chuxiong region of Yunnan Province, southwestern China. Selenium deficiency is evident there in the environment, food chain, and inhabitants. The remaining four isolates were obtained from blood or stool of four patients during outbreaks of
acute myocarditis in the same region in the summers of 1991 and 1992 (Table 1), initially by use of primary
cultures of monkey kidney cells. All these patients had a history of
upper respiratory tract infection and a clinical diagnosis of
myocarditis. Patients 3 and 4 had a fourfold increase in neutralizing
antibody titer against CVB6 (from 1:80 to 1:320), while patients 5 and
6 had a twofold increase in neutralizing antibody titer against CVB4 and CVB6. These isolates were serotyped in two separate institutions, a
virology laboratory in China and the Public Health Laboratory Service
in the United Kingdom, using a standard neutralization assay described
by Melnick et al. (28, 29). A cardiovirulent laboratory
strain of CVB3 was used as a control (40).
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Characterization of Enterovirus Isolates from
Patients with Heart Muscle Disease in a Selenium-Deficient Area
of China
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Clinical data for virus isolates
Cell culture, plaque assay, and single-step growth.
To adapt
these isolates to established cell lines, confluent Vero cell (European
Collection of Cell Cultures [ECACC] no. 88020401) or HEp-2 cell
(ECACC no. 86030501) monolayers were inoculated with 0.1 PFU of virus
per cell. After absorption at room temperature for 1 h, the
cultures were washed twice in phosphate-buffered saline (PBS),
maintained in Dulbecco's modified Eagle medium (DMEM) with 2% fetal
bovine serum, and incubated until there was greater than a 50%
cytopathic effect. After three cycles of freezing-thawing from
70°C
to room temperature, cell debris was removed by centrifugation and the
supernatants were used as virus stock for the following experiments.
20°C at specific times (2, 4, 6, 8, and 10 h postinfection).
After three cycles of freezing-thawing followed by centrifugation,
supernatants were titrated for virus infectivity by a plaque assay.
RNA extraction, RT, and PCR.
Total RNA was extracted from
infected cells (25-cm2 flask) using Tri-reagent (Sigma) and
dissolved in 50 µl of diethyl pyrocarbonate-treated H2O.
The enterovirus-specific primers used for reverse transcription (RT)-PCR and sequencing of the 5'NTR and the VP1 coding region are
shown in Table 2. RT was carried out as
recommended by the manufacturer (Superscript II RNase H-free reverse
transcriptase; GIBCO-BRL) and as described previously (1,
42). PCR was carried out with a 50-µl mixture containing 1 mM
deoxynucleoside triphosphates, 0.5 mM forward primer (various), 0.5 mM
reverse primer (various), 10 µl of reaction buffer (Promega), 1.0 to
2.5 mM MgCl2, 2.5 U of Taq (Promega), and 5 µl
of the RT reaction product. The PCR program was 1 cycle of 2 min at
95°C, 2 min at N°C, and 3 min at 72°C, followed by 30 cycles of 1 min at 95°C, 1 min at N°C, and 2 min at
72°C, where N is 5°C below the annealing temperature of
the primer with the lower melting temperature. A negative control containing 45 µl of the reaction mixture plus 5 µl of UV-treated H2O and a positive control containing 45 µl of the
reaction mixture plus 5 µl of the RT reaction product from cells
infected with the virulent laboratory strain of CVB3 were included in
each set of PCRs.
|
Cycle sequencing and sequence analysis. The cycle sequencing reaction was carried out using 4 µl of DNA polymerase FS-terminator mix (PE-ABI), 3.2 mM primer, and 5 ng of PCR product per 100-bp length of template DNA, with the volume made up to 10 µl with H2O. Reactions were run for 25 cycles with the following program: 96°C for 30 s, 50°C for 15 s, and 60°C for 4 min. DNA was precipitated, dissolved in loading buffer (16.7% formamide, 73.3% dextran), and separated in a 4.1% denaturing polyacrylamide gel on an ABI model 377 DNA sequencer (1, 42). Sequence alignment and analysis were carried out as previously described (24, 42).
Animal experiments. Five-week-old male MF-1 and SWR mice were obtained from HARLEN OLAC Ltd. or Charles River and housed in negative-pressure isolators. The animals were inoculated intraperitoneally with 106 PFU of virus and sacrificed by cervical dislocation at 7 days postinfection. The heart and pancreas were removed and fixed in 10% formalin in PBS for histologic study. One- to 2-day-old MF-1 suckling mice were inoculated subcutaneously with 103 PFU of virus and inspected daily for 10 days, and survival or death was recorded. Mice were inoculated similarly with a cardiovirulent laboratory strain of CVB3 or DMEM as positive and negative controls, respectively, for both adult and suckling mice.
Histology. Paraffin-embedded sections were stained with hematoxylin and eosin by standard procedures. Two slides with two or three sections each, cut 40 µm apart, were prepared from each sample, and histopathologic changes were examined under a light microscope by two investigators independently.
Nucleotide sequence accession numbers. The sequences reported here have been deposited in the GenBank sequence database under accession numbers AF225467 to AF225473.
| |
RESULTS |
|---|
|
|
|---|
Serotype and growth properties of enterovirus isolates. The serotypes of the isolates were determined by the standard neutralization assay as either CVB2 or CVB6 for four of six strains (Table 1). The remaining two isolates were identified in one laboratory as CVB3 but were reported as CVB4 by another laboratory; these two isolates are therefore regarded as nontypeable by the neutralization assay.
Apart from isolate 2, all isolates grew readily in both Vero and HEp-2 cells. Isolate 2 grew in HEp-2 cells but not in Vero cells, indicating different growth properties for isolate 1 and isolate 2 despite the fact that they were the same serotype (CVB2). The replication efficiency of the isolates was assessed under the same condition with HEp-2 cells. Similar patterns of single-step growth were exhibited by the isolates (Fig. 1), and these patterns were similar to that of the cardiovirulent laboratory strain of CVB3 (data not shown). Isolate 1 showed the highest replication in HEp-2 cells, while other isolates exhibited lower infectivity, but within a factor of 10-fold.
|
Sequence analysis and molecular typing. Genomic sequences of the 5'NTR (700 bp) and the 3' half of or the complete VP1 coding region of all six isolates were determined in both orientations without ambiguity. Isolates 1 and 2 had identical sequences in the 5'NTR (700 of 700 bp) and more than 99% sequence identity in VP1 (359 of 360 bp). Isolates 3, 4, 5, and 6 also had more than 99% sequence identity in the VP1 region, but the 5'NTR sequences of isolates 3 and 4 were different from those of isolates 5 and 6 by 17.8%. The different sequences of the 5'NTR or VP1 among the six isolates indicated no cross contamination during virus propagation or RT-PCR and cycle sequencing procedures.
When compared to the sequences in the GenBank DNA database (Table 3), the 5'NTR sequences of the isolates were similar to those of the CVB or echovirus group by up to 93% but differed from the sequences of prototype strains of either CVB2 (CVB2 strain Ohio, accession no. AF081485) or CVB6 (CVB6 strain Schmitt, accession no. AF039205) by 14 to 17.1%, failing to correlate with the serotype determined by the neutralization test.
|
Pathogenicity of isolates in mice.
Animal experiments
confirmed that the virulent laboratory strain of CVB3 caused typical
myocarditis and pancreatitis in adult MF-1 mice, similar to that seen
in the characterized SWR mouse model (41). This result
validates MF-1 mice as an alternative model for viral myocarditis which
could be used to test the pathogenicity of enteroviruses. There were no
obvious pathologic changes in the hearts of MF-1 mice 7 days after
inoculation with any of the isolates (106 PFU/mouse).
Isolate 2 was also inoculated into SWR mice, with similar results.
However, pancreatitis was evident in all mice inoculated with isolate
3, 4, 5, or 6, and enterovirus RNA was detected in myocardium by in
situ hybridization (data not shown). To further characterize
pathogenicity, groups of 10 suckling mice were inoculated with
103 PFU of particular viruses. Isolate 3, 4, 5, or 6 caused
death within 6 days after inoculation, comparable to that seen with the
virulent laboratory strain of CVB3. No mortality was observed for mice
inoculated with isolate 1 or 2 or in negative controls mock infected
with culture medium (Fig. 2).
|
| |
DISCUSSION |
|---|
|
|
|---|
KD has been studied for over 60 years within China. One of the key issues has been the complex etiology of this endemic disease, with a focus on environmental-nutritional factors and infectious agents (6, 8, 11, 13). Selenium deficiency in the food chain has been recognized as a major but not exclusive environmental-nutritional factor, and increasing evidence supports an etiological role of enteroviruses in KD (6, 23, 24, 34, 44, 45). In addition, annual summer outbreaks of fulminant enteroviral myocarditis occurring in similar selenium-deficient areas as KD appear to be more severe, with a higher mortality (15 and our unpublished data). It is important to identify the prevalent virus types and strains in these areas and to investigate their biological properties. Rapid and correct serotyping will make it possible to use hyperimmune globulin or type-specific immune globulin for treatment or passive immunization before and during an outbreak (27, 39). Serotyping will also provide information on the spectrum of viruses involved and will be useful in designing specific vaccines (9, 14, 33, 43).
Various enteroviruses have been isolated from patients with KD or during outbreaks of myocarditis in the Chuxiong region. They have been serotyped by a neutralization assay, but some have failed to be typed by this approach. A recent study has shown that certain sequences within the region coding for capsid protein VP1 correlate with serotype. It is known that VP1 contains major neutralizing antigenic sites, the basis of serotyping by the neutralization assay (29), and an enterovirus can be typed genetically by comparison of partial VP1 sequences to a database of sequences of enterovirus prototype strains or other typed strains (31). These sequences are determined by PCR amplification of part of or the entire VP1 gene with generic RT-PCR primers, designed to react with all known human enterovirus serotypes, followed by nucleotide sequencing of the products. This molecular typing approach has been used to discriminate between prototype strains of all human enterovirus serotypes (30, 31), to identify isolates from clinical specimens, or and to identify isolates refractory to antigenic typing and so to identify potential new viruses.
In this study, we determined the sequences of the 5'NTR and the 3' half of the VP1 coding region of six enterovirus isolates from cases of KD or outbreak myocarditis. Not surprisingly, isolates 1 and 2, from subacute KD cases occurring in the same geographic area, show high nucleotide sequence similarity in both the 5'NTR and the VP1 region (>99%). Similarly, isolates 3 and 4 or isolates 5 and 6, from myocarditis cases occurring in the same geographic area in 1991 or 1992, respectively, have more than 99% nucleotide sequence identity. A partial VP1 sequence alignment correlates with serotype for isolates 1, 2, 3, and 4 and identifies isolates 5 and 6, nontypeable by a conventional neutralization test, as CVB6. However, the 5'NTR sequences of isolates 3 and 4 are dissimilar from those of isolates 5 and 6, indicating that CVB6 strains recovered during outbreaks in 1991 and 1992 are not the same.
CVB6 infection is uncommon in humans. Lau (21) analyzed the level of CVB-specific antibodies in 1,020 normal subjects 1 to 60 years old and from all 18 health districts of New Zealand. CVB6 was the least prevalent, and 970 (95.1%) of the subjects had no antibody to this serotype, compared with 30.4 to 71.3% with antibodies against CVB1 to CVB5. Similar results were obtained from a 5-year clinical and epidemiologic study in France (35), but some studies have suggested that CVB6 is associated with human disease, such as pancreatitis (19) and respiratory tract infection (12), and CVB6 has been isolated from aborted fetal heart, brain, liver, kidney, and spleen tissue (3). Few studies have reported CVB6-induced heart muscle disease, and so it is intriguing to find CVB6 in outbreaks of myocarditis in selenium-deficient areas.
Infection with the same CVB3 strain can cause severe myocarditis and pancreatitis in some strains of mice but can cause only pancreatitis or is avirulent in others because of their different genetic backgrounds (16). SWR mice have been successfully used as a model of CVB3 myocarditis (41, 43), but little is known of their susceptibility to other CVB strains. MF-1 mice have not been used previously as a model for CVB infection. Our study shows the typical pathologic changes of myocarditis and pancreatitis in MF-1 mice after infection with the laboratory strain of CVB3, similar to those seen in SWR mice, suggesting that MF-1 mice could be an alternative model for CVB3-induced myocarditis.
We assessed the pathogenicity of the six isolates in MF-1 mice. Isolate 1 or 2 (CVB2) did not cause pathologic changes in the heart or pancreatitis in adult MF-1 or SWR mice (isolate 2 only) or death in suckling mice (MF-1). A similar result was obtained with a mouse model and a prototype CVB2 strain from the Virus Reference Laboratory, Public Health Laboratory Service, Colindale, London, England, by other authors (20). It is possible that our isolates are not virulent in these mouse strains, although the presence of enterovirus RNA in mouse myocardial tissue suggests virus replication in the heart (17, 37). The remaining four isolates (serotype CVB6) caused pancreatitis in adult MF-1 mice, despite no apparent myocarditis, and caused death in suckling mice, similar to the laboratory strain of CVB3. These results indicate differences in pathogenicity among these isolates and imply that virulence in an experimental mouse model may not reflect pathogenicity in humans (10, 18). Investigation of more isolates from selenium-deficient areas and a search for virulence determinants in viral genomic RNA sequences (4) will provide further information on pathogenicity.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported by the Ministry of Public Health of the People's Republic of China, (grant 95-397), the Yunnan Scientific Commission, the Wellcome Trust, (grant 052954Z97), and University of London Central Funds and partially by the British Heart Foundation.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Molecular Pathology Section, Division of Biomedical Sciences, Department of Infectious Diseases and Medical Microbiology, Imperial College of Science, Technology and Medicine, London SW7 2AZ, United Kingdom. Phone: 44 (0)20 7594 3005. Fax: 44 (0)20 7594 3022. E-mail: h.zhang{at}ic.ac.uk.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Archard, L. C., M. A. Khan, B. A. Soteriou, H. Zhang, H. J. Why, N. M. Robinson, and P. J. Richardson. 1998. Characterization of coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products. Hum. Pathol. 29:578-584[CrossRef][Medline]. |
| 2. | Arola, A., J. Santti, O. Ruuskanen, P. Halonen, and T. Hyypia. 1996. Identification of enteroviruses in clinical specimens by competitive PCR followed by genetic typing using sequence analysis. J. Clin. Microbiol. 34:313-318[Abstract]. |
| 3. | Basso, N. G., M. E. Fonseca, A. G. Garcia, J. A. Zuardi, M. R. Silva, and H. Outani. 1990. Enterovirus isolation from foetal and placental tissues. Acta Virol. 34:49-57[Medline]. |
| 4. | Beck, M. A., Q. Shi, and V. C. Morris. 1995. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat. Med. 1:433-436[CrossRef][Medline]. |
| 5. | Bowles, N. E., P. J. Richardson, and E. J. Olsen. 1986. Detection of coxsackie B virus specific sequences in myocardial biopsies from cases of myocarditis and dilated cardiomyopathy. Lancet 1:1120-1122[Medline]. |
| 6. | Department of Microbiology. 1978. Investigation of biological aetiology of Keshan disease. J. Chongqing Med. Coll. 2:1-5. |
| 7. | Druyts-Voets, E., L. V. Renterghem, and S. Gerniers. 1993. Coxsackie B virus epidemiology and neonatal infection in Belgium. J. Infect. 27:311-316[CrossRef][Medline]. |
| 8. | Ecology Study Group. 1988. Ecological environment of Keshan disease in Chuxiong region, p. 48-83. In W. H. Yu, and F. Wang (ed.), Proceedings of comprehensive scientific investigation of KD in Chuxiong region. People's Health Press, Beijing, China. |
| 9. | Fohlman, J., K. Pauksen, B. Morein, U. Bjare, N. G. Ilback, and G. Friman. 1993. High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis. Scand. J. Infect. Dis. Suppl. 88:103-108[Medline]. |
| 10. | Gauntt, C. J., and M. A. Pallansch. 1996. Coxsackievirus B3 clinical isolates and murine myocarditis. Virus. Res. 41:89-99[CrossRef][Medline]. |
| 11. |
Ge, K. Y., and G. Yang.
1993.
The epidemiology of selenium deficiency in the etiological study of endemic diseases in China.
Am. J. Clin. Nutr.
57(Suppl. 2):259S-263S |
| 12. | Goldwater, P. N. 1995. Immunoglobulin M capture immunoassay in investigation of coxsackievirus B5 and B6 outbreaks in South Australia. J. Clin. Microbiol. 33:1628-1631[Abstract]. |
| 13. | Gu, B. Q., and T. O. Cheng. 1986. Keshan disease, p. 752-765. In T. O. Cheng (ed.), The international textbook of cardiology. Pergamon Press, New York, N.Y. |
| 14. |
Henke, A.,
E. Wagner,
J. L. Whitton,
R. Zell, and A. Stelzner.
1998.
Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization.
J. Virol.
72:8327-8331 |
| 15. | Hou, L. C., X. Q. Deng, X. Liang, and C. L. Niu. 1992. An outbreak of acute viral myocarditis in Chuxiong. Chin. J. Endemiol. 11:373-375. |
| 16. |
Huber, S. A.,
J. E. Stone,
D. H. Wagner,
J. Kupperman,
L. Pfeiffer,
C. David,
R. L. O'Brien,
G. S. Davis, and M. K. Newell.
1999.
![]() + T cells regulate major histocompatibility complex class II (IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditis.
J. Virol.
73:5630-5636 |
| 17. |
Huber, S. A.
1996.
Modulation of cytokine expression by CD4+ T cells during coxsackievirus B3 infections of BALB/c mice initiated by cells expressing the ![]() + T-cell receptor.
J. Virol.
70:3039-3044[Abstract].
|
| 18. | Kuno, S., A. Itagaki, I. Yamazaki, T. Katsumoto, and T. Kurimura. 1984. Pathogenicity of newly isolated coxsackievirus B4 for mouse pancreas. Acta Virol. 28:433-436[Medline]. |
| 19. | Lal, S. M., D. Fowler, C. J. Losasso, and G. G. Berg. 1988. Coxsackie virus-induced acute pancreatitis in a long-term dialysis patient. Am. J. Kidney Dis. 11:434-436[Medline]. |
| 20. | Lansdown, A. B. 1976. Pathological changes in the pancreas of mice following infection with coxsackie B viruses. Br. J. Exp. Pathol. 57:331-338[Medline]. |
| 21. | Lau, R. C. 1983. Coxsackie B virus infections in New Zealand patients with cardiac and non-cardiac diseases. J. Med. Virol. 11:131-137[Medline]. |
| 22. | Li, G. S., F. Wang, and D. R. Kang. 1985. Keshan disease: an endemic cardiomyopathy in China. Hum. Pathol. 16:602-609[Medline]. |
| 23. | Li, Y. W., Y. Z. Yang, and H. Z. Chen. 1995. Detection of enteroviral RNA in paraffin-embedded myocardial tissue from patients with Keshan disease by nested PCR. Natl. Med. J. China 75:344-345. |
| 24. |
Li, Y. W.,
T. Q. Peng,
Y. Z. Yang,
C. L. Niu,
L. C. Archard, and H. Y. Zhang.
2000.
High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China.
Heart
83:696-701 |
| 25. | Manolio, T. A., K. L. Baughman, R. Rodeheffer, T. A. Pearson, J. D. Bristow, V. V. Michels, W. H. Abelmann, and W. R. Harlan. 1992. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am. J. Cardiol. 69:1458-1466[CrossRef][Medline]. |
| 26. |
Martino, T. P.,
P. Liu, and M. J. Sole.
1994.
Viral infection and the pathogenesis of dilated cardiomyopathy.
Circ. Res.
74:182-188 |
| 27. |
McNamara, D. M.,
W. D. Rosenblum,
K. M. Janosko,
M. K. Trost,
F. S. Villaneuva,
A. J. Demetris,
S. Murali, and A. M. Feldman.
1997.
Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy.
Circulation
95:2476-2478 |
| 28. | Melnick, J. L., V. Rennick, B. Hampil, N. J. Schmidt, and H. H. Ho. 1973. Lyophilized combination pools of enterovirus equine antisera: preparation and test procedures for the identification of field strains of 42 enteroviruses. Bull. W. H. O. 48:263-268[Medline]. |
| 29. | Melnick, J. L. 1996. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, p. 655-712. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Channock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Stranus (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa. |
| 30. |
Oberste, M. S.,
K. Maher,
D. R. Kilpatrick, and M. A. Pallansch.
1999.
Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification.
J. Virol.
73:1941-1948 |
| 31. |
Oberste, M. S.,
K. Maher,
D. R. Kilpatrick,
M. R. Flemister,
B. A. Brown, and M. A. Pallansch.
1999.
Typing of human enteroviruses by partial sequencing of VP1.
J. Clin. Microbiol.
37:1288-1293 |
| 32. | Oberste, M. S., K. Maher, and M. A. Pallansch. 1998. Molecular phylogeny of all human enterovirus serotypes based on comparison of sequences at the 5' end of the region encoding VP2. Virus Res. 58:35-43[CrossRef][Medline]. |
| 33. | See, D. M., and J. G. Tilles. 1994. Efficacy of a polyvalent inactivated-virus vaccine in protecting mice from infection with clinical strains of group B coxsackieviruses. Scand. J. Infect. Dis. 26:739-747[Medline]. |
| 34. | Su, C. Q., G. M. Gong, and Q. Li. 1979. Preliminary summary of viral aetiology of Keshan disease. Chin. Med. J. 59:466-470. |
| 35. | Wattre, P., O. Leroy, A. Dewilde, and C. Thery. 1987. Coxsackie B virus infections in cardiology. Apropos of 66 cases. Pathol. Biol. (Paris) 35:347-352[Medline]. |
| 36. |
Williams, D. G., and E. G. Olsen.
1985.
Prevalence of overt dilated cardiomyopathy in two regions of England.
Br. Heart J.
54:153-155 |
| 37. | Wolfgram, L. J., K. W. Beisel, A. Herskowitz, and N. R. Rose. 1986. Variations in the susceptibility to coxsackie B3 virus induced myocarditis among different strains of mice. J. Immunol. 136:1846-1852[Abstract]. |
| 38. | Woodruff, J. F. 1980. Viral myocarditis: a review. Am. J. Pathol. 101:425-483[Medline]. |
| 39. | Yoshida, H., M. Morita, N. Kobayashi, O. Takeuchi, S. Wakita, T. Hachisu, M. Hara, and T. Suzuki. 1999. Efficacy of immunized milk for preventing viral infection. Kansenshogaku Zasshi 73:122-129[Medline]. |
| 40. | Zhang, H. Y., G. E. Yousef, L. Cunningham, N. W. Blake, X. Ouyang, T. A. Bayston, R. Kandolf, and L. C. Archard. 1993. Attenuation of a reactivated cardiovirulent coxsackievirus B3: the 5'-nontranslated region does not contain major attenuation determinants. J. Med. Virol. 41:129-137[CrossRef][Medline]. |
| 41. | Zhang, H. Y., G. E. Yousef, X. M. Ouyang, and L. C. Archard. 1994. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3. Int. J. Exp. Pathol. 75:99-110[Medline]. |
| 42. | Zhang, H. Y., B. Soteriou, S. Knowlson, A. Theodoridou, and L. C. Archard. 1997. Characterisation of genomic RNA of coxsackievirus B3 in murine myocarditis: reliability of direct sequencing of reverse transcription-nested polymerase chain reaction products. J. Virol. Methods 69:7-17[CrossRef][Medline]. |
| 43. | Zhang, H. Y., P. Morgan-Capner, N. Latif, Y. A. Pandolfino, W. Fan, M. J. Dunn, and L. C. Archard. 1997. Coxsackievirus B3-induced myocarditis: characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain. Am. J. Pathol. 150:2197-2207[Abstract]. |
| 44. | Zhong, X. K., Y. C. Zhou, and W. H. Yu. 1987. Detection of coxsackievirus B neutralization antibodies in sera from children with Keshan disease. Chin. J. Endemiol. 6:356-358. |
| 45. | Zhong, X. K., F. M. Zhang, and Z. R. Jiang. 1993. Relationship between coxsackie B viruses and subacute Keshan disease in Yunnan Province using in situ hybridization. Chin. J. Endemiol. 12:193-195. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»